SCM
CRBP icon

Sterling Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Sterling Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.11K Buy
+332
New +$3.14K ﹤0.01% 2851
2025
Q2 		– Sell
-86
Closed -$457 – 3291
2025
Q1 		$457 Sell
86
-58
-40% -$512 ﹤0.01% 2970
2024
Q4 		$1.7K Buy
144
+125
+658% +$2.1K ﹤0.01% 2820
2024
Q3 		$392 Buy
+19
New +$972 ﹤0.01% 2966

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Sterling Capital Management's CRBP Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Corbus Pharmaceuticals (CRBP) in Q2 2026: 332 shares worth $3.11K. The stake represents ﹤0.01% of the portfolio and ranks #2851 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in CRBP as recently as Q1 2025.

Sterling Capital Management first reported a position in CRBP in Q3 2024 and has held it in 4 quarters since. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Sterling Capital Management held 332 shares of Corbus Pharmaceuticals worth $3.11K as of Q2 2026.
  • Corbus Pharmaceuticals was a new Sterling Capital Management position in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2851 holding.
  • Sterling Capital Management first reported a position in Corbus Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.